SCHEMBL4732149

SCHEMBL4732149

CC(C)(C)ON(C=O)CCC(CO)Cc1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.36
ATM Q13315 1/20 0.35
HPGD P15428 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
TAAR1 Q96RJ0 1/20 0.33
CHRM1 P11229 1/20 0.33
IDO1 P14902 1/20 0.33
OPRM1 P35372 1/20 0.32
OPRD1 P41143 1/20 0.32
OPRK1 P41145 1/20 0.32
CTRB1 P17538 1/20 0.32
ALDH1A1 P00352 1/20 0.32
THRB P10828 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
HSD17B10 Q99714 1/20 0.32
CYP3A4 P08684 1/20 0.32
MAPK1 P28482 1/20 0.32
EPHX1 P07099 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4729185 0.87 TRPA1 (0.37) TRPA1ATMHPGDMEN1KMT2A
SCHEMBL6949347 0.76 TAAR1 (0.44) MEN1KMT2ATAAR1CHRM1OPRM1
SCHEMBL8878079 0.76 ATM (0.38) TRPA1ATMMEN1KMT2ATAAR1
SCHEMBL4729192 0.73 OPRK1 (0.40) TRPA1ATMMEN1KMT2ATAAR1
SCHEMBL6400372 0.73 OPRK1 (0.40) TRPA1ATMMEN1KMT2ATAAR1
SCHEMBL7763429 0.73 MEN1 (0.41) MEN1KMT2AALDH1A1CYP2C19CTSB
SCHEMBL4895988 0.71 OPRK1 (0.38) TRPA1ATMMEN1KMT2ATAAR1
SCHEMBL942894 0.69 KMT2A (0.53) HPGDMEN1KMT2AALDH1A1CYP2C19
SCHEMBL4730804 0.68 SMN1; SMN2 (0.37) ATMHPGDMEN1KMT2ACTRB1
SCHEMBL28233244 0.68 CYP1A2 (0.41) ATMOPRM1OPRD1OPRK1CTRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080242694-A1 Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith D SIDOCKY NEIL R 2008-10-02 US disclosed
WO-2008036308-A2 AMINO-SUBSTITUTED HETEROCYCLES, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH SIGNAL PHARMACEUTICALS, LLC (US) 2008-03-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080242694-A1 Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith JAK2, CHEK2, MTOR TRPA1 3956/4885ATM 45/4885HPGD 346/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.